MDCX
MDCX
NASDAQ · Biotechnology

Medicus Pharma Ltd

$0.34
+0.02 (+6.69%)
As of May 16, 2:24 AM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +2,120.9% upside
Low Target $4.65
Average Target $7.44
High Target $8.88
Current Price $0.34
Current
$0.34
Target
$7.44
$4.65 $7.44 avg $8.88
Scenario Analysis
Bear Case
$4.65
1,288.1%
Low target
Base Case
$7.44
+2,120.9%
Avg target
Bull Case
$8.88
+2,550.7%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$8.94
-96.3% from high
52-Week Low
$0.25
+34.0% from low
Target vs 52W High
$7.44
-16.8% vs high
Next Earnings Report
May 28, 2026
11d
until earnings
EPS Est: $-0.20
Earnings in 11 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 75% $257.58 +22.4%
AMGN
Amgen Inc
Hold 44 48% $190.87 -41.5%
GILD
Gilead Sciences Inc
Strong Buy 39 79% $362.68 +179.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 +0.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 38 79% $76.80 -89.0%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -64.3%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -21.7%
BIIB
Biogen Inc
Buy 43 56% $91.45 -52.6%